Bank of New York Mellon’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $932M | Sell |
9,013,571
-16,590
| -0.2% | -$1.48M | 0.15% | 117 |
|
|
2026
Q1 | $649M | Sell |
9,030,161
-80,415
| -0.9% | -$6.19M | 0.12% | 164 |
|
|
2025
Q4 | $723M | Buy |
9,110,576
+577,064
| +7% | +$45.5M | 0.13% | 148 |
|
|
2025
Q3 | $643M | Sell |
8,533,512
-122,098
| -1% | -$8.37M | 0.12% | 158 |
|
|
2025
Q2 | $597M | Sell |
8,655,610
-325,652
| -4% | -$21.4M | 0.11% | 170 |
|
|
2025
Q1 | $608M | Buy |
8,981,262
+183,813
| +2% | +$11M | 0.12% | 166 |
|
|
2024
Q4 | $395M | Sell |
8,797,449
-527,213
| -6% | -$29.6M | 0.07% | 237 |
|
|
2024
Q3 | $586M | Sell |
9,324,662
-461,140
| -5% | -$26.9M | 0.11% | 177 |
|
|
2024
Q2 | $578M | Sell |
9,785,802
-280,299
| -3% | -$17.5M | 0.11% | 172 |
|
|
2024
Q1 | $803M | Sell |
10,066,101
-333,117
| -3% | -$25.4M | 0.15% | 127 |
|
|
2023
Q4 | $821M | Sell |
10,399,218
-278,860
| -3% | -$19.8M | 0.17% | 122 |
|
|
2023
Q3 | $746M | Buy |
10,678,078
+266,650
| +3% | +$18.9M | 0.16% | 121 |
|
|
2023
Q2 | $720M | Sell |
10,411,428
-2,513,267
| -19% | -$179M | 0.15% | 126 |
|
|
2023
Q1 | $960M | Sell |
12,924,695
-497,053
| -4% | -$41.7M | 0.21% | 104 |
|
|
2022
Q4 | $1.25B | Sell |
13,421,748
-596,026
| -4% | -$57.5M | 0.29% | 71 |
|
|
2022
Q3 | $1.34B | Sell |
14,017,774
-805,535
| -5% | -$79.7M | 0.32% | 60 |
|
|
2022
Q2 | $1.37B | Sell |
14,823,309
-1,205,319
| -8% | -$118M | 0.31% | 64 |
|
|
2022
Q1 | $1.62B | Buy |
16,028,628
+1,385,322
| +9% | +$146M | 0.31% | 59 |
|
|
2021
Q4 | $1.51B | Buy |
14,643,306
+422,269
| +3% | +$39M | 0.27% | 73 |
|
|
2021
Q3 | $1.21B | Buy |
14,221,037
+15,930
| +0.1% | +$1.33M | 0.24% | 81 |
|
|
2021
Q2 | $1.19B | Buy |
14,205,107
+1,107,604
| +8% | +$90.7M | 0.23% | 82 |
|
|
2021
Q1 | $985M | Buy |
13,097,503
+508,844
| +4% | +$37.1M | 0.2% | 95 |
|
|
2020
Q4 | $860M | Sell |
12,588,659
-456,795
| -4% | -$29.7M | 0.19% | 100 |
|
|
2020
Q3 | $762M | Sell |
13,045,454
-169,169
| -1% | -$10.5M | 0.19% | 100 |
|
|
2020
Q2 | $859M | Sell |
13,214,623
-916,776
| -6% | -$57.7M | 0.23% | 85 |
|
|
2020
Q1 | $838M | Sell |
14,131,399
-296,793
| -2% | -$19.8M | 0.28% | 77 |
|
|
2019
Q4 | $1.07B | Sell |
14,428,192
-364,588
| -2% | -$25.6M | 0.28% | 76 |
|
|
2019
Q3 | $933M | Buy |
14,792,780
+1,140,853
| +8% | +$67.6M | 0.26% | 78 |
|
|
2019
Q2 | $744M | Sell |
13,651,927
-867,343
| -6% | -$46.7M | 0.2% | 96 |
|
|
2019
Q1 | $783M | Sell |
14,519,270
-82,609
| -0.6% | -$5.1M | 0.22% | 91 |
|
|
2018
Q4 | $957M | Buy |
14,601,879
+2,030,920
| +16% | +$152M | 0.3% | 70 |
|
|
2018
Q3 | $990M | Sell |
12,570,959
-2,379
| -0% | -$170K | 0.25% | 73 |
|
|
2018
Q2 | $809M | Buy |
12,573,338
+1,729,283
| +16% | +$114M | 0.22% | 83 |
|
|
2018
Q1 | $675M | Buy |
10,844,055
+138,565
| +1% | +$9.94M | 0.19% | 106 |
|
|
2017
Q4 | $776M | Buy |
10,705,490
+126,183
| +1% | +$9.17M | 0.2% | 93 |
|
|
2017
Q3 | $860M | Buy |
10,579,307
+481,262
| +5% | +$38.1M | 0.24% | 80 |
|
|
2017
Q2 | $812M | Sell |
10,098,045
-924,875
| -8% | -$73M | 0.23% | 83 |
|
|
2017
Q1 | $865M | Sell |
11,022,920
-44,447
| -0.4% | -$3.55M | 0.24% | 82 |
|
|
2016
Q4 | $873M | Buy |
11,067,367
+1,087,777
| +11% | +$88M | 0.25% | 80 |
|
|
2016
Q3 | $888M | Sell |
9,979,590
-461,948
| -4% | -$43.6M | 0.26% | 75 |
|
|
2016
Q2 | $1,000M | Sell |
10,441,538
-1,569,385
| -13% | -$156M | 0.31% | 70 |
|
|
2016
Q1 | $1.25B | Sell |
12,010,923
-676,444
| -5% | -$65.8M | 0.38% | 55 |
|
|
2015
Q4 | $1.24B | Sell |
12,687,367
-2,899,986
| -19% | -$284M | 0.37% | 55 |
|
|
2015
Q3 | $1.5B | Buy |
15,587,353
+415,547
| +3% | +$43.7M | 0.46% | 41 |
|
|
2015
Q2 | $1.59B | Sell |
15,171,806
-793,834
| -5% | -$81.1M | 0.44% | 44 |
|
|
2015
Q1 | $1.65B | Sell |
15,965,640
-784,513
| -5% | -$79.4M | 0.43% | 42 |
|
|
2014
Q4 | $1.61B | Sell |
16,750,153
-249,172
| -1% | -$22M | 0.42% | 45 |
|
|
2014
Q3 | $1.35B | Sell |
16,999,325
-643,620
| -4% | -$50.7M | 0.37% | 54 |
|
|
2014
Q2 | $1.33B | Sell |
17,642,945
-117,059
| -0.7% | -$8.85M | 0.36% | 51 |
|
|
2014
Q1 | $1.33B | Sell |
17,760,004
-437,868
| -2% | -$30.9M | 0.36% | 52 |
|
|
2013
Q4 | $1.3B | Sell |
18,197,872
-593,725
| -3% | -$38.1M | 0.36% | 52 |
|
|
2013
Q3 | $1.07B | Buy |
18,791,597
+125,273
| +0.7% | +$7.46M | 0.32% | 57 |
|
|
2013
Q2 | $1.07B | Buy |
+18,666,324
| New | +$1.08B | 0.34% | 57 |
|
Other funds holding CVS
Bank of New York Mellon's CVS Position: Q2 2026 in Review
Bank of New York Mellon reduced its CVS Health (CVS) stake by 0.18% in Q2 2026, selling an estimated $1.48M and leaving 9,013,571 shares worth $932M. The position accounts for 0.15% of the portfolio, ranked #117.
Bank of New York Mellon first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.65B in Q1 2015. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Bank of New York Mellon held 9,013,571 shares of CVS Health worth $932M as of Q2 2026.
- Bank of New York Mellon sold 16,590 CVS Health shares in Q2 2026, an estimated $1.48M.
- CVS Health made up 0.15% of Bank of New York Mellon's portfolio in Q2 2026, its #117 holding.
- Bank of New York Mellon first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's CVS Health position peaked at $1.65B in Q1 2015.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.